Dovobet Side Effects

Generic name: betamethasone / calcipotriene topical

Note: This document contains side effect information about betamethasone / calcipotriene topical. Some of the dosage forms listed on this page may not apply to the brand name Dovobet.

Some side effects of Dovobet may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

For the Consumer

Applies to betamethasone / calcipotriene topical: topical ointment, topical suspension

Get emergency medical help if you have any of these signs of an allergic reaction while taking betamethasone / calcipotriene topical: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using betamethasone and calcipotriene and call your doctor at once if you have any of these serious side effects:

• severe skin irritation on treated areas;

• worsened symptoms or no improvement in psoriasis;

• pus, swelling, redness, increased itching, or other signs of skin infection;

• confusion, thirst, extreme tiredness, lost appetite, weight loss;

• adrenal insufficiency--nausea, vomiting, lost appetite, tiredness, trouble breathing, joint/muscle pain, feeling light-headed, fainting;

• Cushing syndrome--weight gain (especially in your face), thinning muscles in your arms or legs, easy bruising, thinning skin, acne, increased facial hair, darkened skin; or

• high blood sugar (hyperglycemia)--increased urination and thirst, nausea, vomiting.

Less serious side effects of betamethasone / calcipotriene topical may include:

• burning or mild itching;

• red or scaly rash;

• swollen hair follicles; or

• changes in the color of treated skin areas.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to betamethasone / calcipotriene topical: topical ointment, topical suspension

Dermatologic

Common (1% to 10%): Ointment: Pruritus (up to 7.2%), psoriasis (up to 3.4%), skin atrophy (up to 1.9%), folliculitis (up to 1.4%), skin depigmentation (1.4%), scaly rash (1.2%), hand dermatitis (1%); Suspension: Pruritus (3.6%), psoriasis (2.4%), erythema (2.1%), skin irritation (1.4%), folliculitis (up to 1.2%)
Uncommon (0.1% to 1%): Ointment: Erythema (up to 1%), skin irritation (0.4%), papular rash (greater than 0.1% and less than 1%), pustular rash (greater than 0.1% and less than 1%), skin hypopigmentation (greater than 0.1% and less than 1%), telangiectasia (0.1%), skin hyperpigmentation (0.1%); Suspension: Acne (greater than 0.1% and less than 1%), exacerbation of psoriasis (greater than 0.1% and less than 1%), rash (greater than 0.1% and less than 1%), pustular rash (greater than 0.1% and less than 1%)
Rare (less than 0.1%): Ointment: Serious flare-up of psoriasis (at least 1 case)
Postmarketing reports: Ointment: Pustular psoriasis

Nervous system

Common (1% to 10%): Ointment: Headache (2.8%)

Metabolic

Frequency not reported: Hypercalcemia, hypercalciuria

Endocrine

Frequency not reported: Adrenal suppression; Ointment: Hypothalamic-pituitary-adrenal axis suppression

Hypersensitivity

Frequency not reported: Allergic contact dermatitis

Respiratory

Common (1% to 10%): Ointment: Nasopharyngitis (2.3%)
Uncommon (0.1% to 1%): Ointment: Influenza (0.9%), upper respiratory tract infection (0.8%)

Other

Common (1% to 10%): Ointment: Burning sensation (up to 1.4%); Suspension: Burning sensation of skin (1%)
Uncommon (0.1% to 1%): Ointment: Pain (0.3%)
Postmarketing reports: Ointment: Rebound effect

Hematologic

Common (1% to 10%): Ointment: Ecchymosis (1%)

Local

Uncommon (0.1% to 1%): Ointment: Application site pruritus (0.5%)

Ocular

Uncommon (0.1% to 1%): Suspension: Eye irritation (greater than 0.1% and less than 1%)

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.